Dr. Agarwal's Health Care Ltd.

AGARWALEYENSEHealthcareHospital & Healthcare ServicesSmall Cap

₹466.65

▲ 4.91%

loading…

Composite

The company and its subsidiaries/associate are primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc.

www.dragarwals.co.inSector: HealthcareIndustry: Hospital & Healthcare Services

Q-DITS fundamental score

43Composite

Growth

Profitability

Valuation

Quality

Solvency

Earnings

100

Key metrics

MCap

₹14.8K Cr

TTM PE

111.3x

Industry PE

64.6x

TTM EPS

₹4.2

Book Value

₹63.9

Face Value

₹1

Div Yield

PEG

—

7.6x

ROE

6.9%

ROCE

14.3%

EBITDA mgn

29.7%

D/E

0.13

Int. Cover

2.4x

Curr. Ratio

1.66x

EPS

₹2.64

Growth — CAGR across horizons

Metric	1Y	3Y	5Y	10Y
Net Sales	21.6%	—	—	—
EBITDA	24.8%	—	—	—
Net Profit	54.6%	—	—	—

Score snapshot

Piotroski

4/9

Altman Z

1.31

Quality

42.8

Growth

57.3

Valuation

Earn. Qual

100

PEAD

-1

SURGE

-1

Loading price data…

Loading delivery data…

Revenue, profitability & returns

Revenue & Net Profit (₹ Cr)

RevenueNet Profit

Margins (%)

EBITDA%PAT%

Return ratios (%)

ROEROCEROA

Annual financials — last 6 years

Tap a row to expand the full chart

Metric	2020	2021	2022	2023	2024	2025
›RevenueCr	531	471	696	1,018	1,332	1,711
›EBITDACr	136	90	203	288	411	506
›EBITDA margin	25.7%	19.2%	29.2%	28.3%	30.9%	29.7%
›Net profitCr	-20	-58	43	103	95	110
›PAT margin	-3.7%	-12.4%	6.2%	10.1%	7.1%	6.4%
›EPS₹	₹-1	₹-2.7	₹1.83	₹3.96	₹2.97	₹2.64
›Revenue growth	0%	-11.2%	47.7%	46.2%	30.9%	28.4%
›PAT growth	0%	-197.1%	173.9%	139.2%	-7.9%	16.1%
›ROE	-7.9%	-26.9%	21.8%	24.6%	9.7%	6.9%
›ROCE	10.5%	-1.1%	24.3%	21.5%	17.8%	14.3%
›ROA	-2.7%	-7.7%	4.8%	7.4%	4.2%	3.5%
›P/E	0x	0x	0x	0x	0x	169.2x
›P/B	0x	0x	0x	0x	0x	7.6x
›D/E	0.7	1	1.4	0.6	0.3	0.1
›Current ratio	1x	1x	1.1x	1x	1.9x	1.7x
›Interest cover	0.8x	-0.1x	2.2x	2.1x	2.4x	2.4x

Quarterly results

Tap a row to expand the full chart

Metric	2023-12	2024-03	2024-06	2024-09	2024-12	2025-03	2025-06	2025-09	2025-12	2026-03
›RevenueCr	333	349	403	417	431	460	487	499	530	564
›Rev growth YoY	—	—	—	—	29.5%	31.9%	20.8%	19.7%	23%	22.6%
›EBITDACr	89	107	104	107	115	131	128	136	144	161
›EBITDA margin	26.7%	30.7%	25.7%	25.7%	26.7%	28.5%	26.2%	27.3%	27.2%	28.6%
›Net profitCr	23	41	18	21	28	43	38	36	44	50
›PAT growth YoY	—	—	—	—	25%	3%	108.9%	71%	54.5%	17.4%
›EPS₹	₹21.24	₹41.53	₹1.28	₹0.54	₹0.72	₹1.03	₹0.95	₹0.94	₹1.07	₹1.25

Balance sheet — last 7 years (₹ Cr)

Tap a row to expand the full chart

Metric	2020	2021	2022	2023	2024	2025	2026
›Shareholders' equityCr	249	184	212	630	1,339	1,867	2,025
›ReservesCr	242	177	206	620	1,324	1,825	1,994
›Total borrowingsCr	0	0	0	0	0	0	0
›InvestmentsCr	36	34	55	101	564	433	0
›Total assetsCr	605	636	819	1,521	2,352	3,187	3,942
›Current assetsCr	146	154	227	310	759	794	573
›Current liabilitiesCr	146	150	206	301	400	478	461
›Trade payablesCr	64	75	89	101	133	153	149
›Gross blockCr	738	854	1,082	1,794	2,399	3,397	926

Cash flow statement (₹ Cr)

Tap a row to expand the full chart

Metric	2020	2021	2022	2023	2024	2025	2026
›Operating CF (CFO)Cr	103	99	164	233	346	360	519
›Investing CF (CFI)Cr	-80	-37	-155	-509	-914	-750	-308
›Financing CF (CFF)Cr	-73	-37	35	303	553	382	-220
›Net cash changeCr	-50	25	44	27	-15	-8	-10
›Closing cashCr	39	55	100	127	112	104	91

Cash flow components

CFO · CFI · CFF (₹ Cr)

CFOCFICFF

Q-DITS scorecard

Composite score

Quality (25%)42.8

Growth (25%)57.3

Valuation (20%)0

Piotroski (15%)44

Earnings Quality (10%)100

Momentum (5%)—

Weighted blend, rescaled to the components available for this stock.

Piotroski F-Score

4/9

✓ROA positiveROA 3.47%

✓CFO positiveCFO ₹518.99 Cr

✗ROA improving4.24% → 3.47%

✓CFO > PAT (low accruals)CFO 518.99 vs PAT 110.34

✓Leverage decreasedD/E 0.29 → 0.13

✗Liquidity improvedCR 1.9 → 1.66

✗No share dilutionEPS 2.97 → 2.64

✗Margin improvedEBITDA mgn 30.89% → 29.74%

✗Asset turnover upAsset TO 0.59 → 0.54

Altman Z-Scoregrey

1.31

0.028

0.506

0.07

0.514

0.434

>2.9 safe · 1.23–2.9 grey · <1.23 distress

Quality

42.8/100

ROE

6.9%

ROCE

14.3%

Margin

6.4%

Debt

0.1

Int. cover

2.4x

Growth

57.3/100

Revenue 3Y

21.6%

Profit 3Y

54.6%

EPS

-11%

Valuation

0/100

169.2x

7.6x

EV/EBITDA

27.9x

vs universe median: PE 25.6x · PB 2.81x · EV 13.41x

Earnings quality

100/100

CFO₹519 Cr

PAT₹110 Cr

Accrual ratio-0.104

CFO/PAT4.7x

PEAD · SURGE

-1 / -1

Revenue SUE-0.5

EPS SUE-0.48

Latest quarter2026-03

Rev growth YoY22.6%

Shareholding pattern

Promoter32.4%

FII/FPI57.9%

DII7.8%

Public67.6%

Tap a row to expand the full chart

Metric	2025-03	2025-06	2025-09	2025-12	2026-03
›Promoter	32.5%	32.4%	32.4%	32.4%	32.4%
›FII / FPI	60.6%	59.3%	58.1%	58.1%	57.9%
›DII	5.2%	6.4%	7.9%	7.8%	7.8%
›Public / Retail	67.6%	67.6%	67.6%	67.6%	67.6%
›Promoter pledge	0%	0%	0%	0%	0%

Documents & filings

Loading documents…

Peer comparison

Company	MCap (Cr)	Revenue	PAT	PE	PB	ROE%	ROCE%	D/E
Apollo Hospitals Enterprise Ltd.	1,22,171	25,229	1,958	62.9x	12.9x	20.5	21.2	0.67
Max Healthcare Institute Ltd.	1,06,672	8,373	1,442	74x	9.9x	12.2	14.7	0.27
Fortis Healthcare Ltd.	72,699	9,128	1,048	69.8x	7.3x	9.8	12.1	0.25
Aster DM Healthcare Ltd.	41,916	4,643	464	108x	9.2x	9.3	11.5	0.19
Narayana Hrudayalaya Ltd.	38,374	7,896	816	47.6x	8.5x	24.3	21.6	0.61
Global Health Ltd.	33,993	4,410	554	61.1x	8.6x	15.3	20.5	0.1
Krishna Institute of Medical Sciences Ltd	32,197	3,905	239	133.4x	14.3x	20.9	19	0.89